<unk> (injection) is an antitubercular, anti-bacterial agent that is FDA approved for the treatment of for all forms of tuberculosis in which organisms are susceptible, persons with human immunodeficiency virus (HIV) infection (≥5 mm), close contacts of persons with newly diagnosed infectious tuberculosis (≥5 mm), recent converters, as indicated by a tuberculin skin test (≥10 mm increase within a 2-year period for those <35 years old; ≥15 mm increase for those ≥35 years of age), persons with abnormal chest radiographs that show fibrotic lesions likely to represent old healed tuberculosis (≥5 mm) and intravenous drug users known to be HIV-seronegative (>10 mm). There is a Black Box Warning for this drug as shown here.  Common adverse reactions include peripheral neuropathy, paresthesias of the feet and hands, nausea, vomiting, and epigastric distress, elevated liver enzymes, fatigue, malaise, and weakness.
Isoniazid 
Ethambutol
Pyrazinamide
Safinamide
Ipriflavone
Rifampin isoniazid
Rifampin 
Monoxerutin